New data show Rybrevant plus Lazcluze extends overall survival in patients with EGFR-mutated non-small cell lung cancer, with the median survival benefit expected to exceed one year compared to osimertinib.
New data show Rybrevant plus Lazcluze extends overall survival in patients with EGFR-mutated non-small cell lung cancer, with the median survival benefit expected to exceed one year compared to osimertinib.
Read More
Researchers from UC San Francisco have uncovered evidence that microplastics in the air—shed from tires and degrading garbage—could be linked to serious health risks, including lung and colon cancers.
Read More
Gilead Sciences’ Trodelvy receives FDA Breakthrough Therapy Designation for the treatment of extensive-stage small cell lung cancer.
Read More
The FDA says the approval marks the first systemic therapy for non–small cell lung cancer and pancreatic adenocarcinoma harboring NRG1 gene fusions.
Read More
AstraZeneca’s Imfinzi (durvalumab) has been approved in the United States for the treatment of adult patients with limited-stage small cell lung cancer.
Read More
A growing number of engineered stone countertop workers are developing silicosis, a preventable lung disease linked to high silica dust exposure.
Read More
The widely used diabetes drug seems to strengthen the immune system’s tumor-killing response in overweight and obese lung cancer patients.
Read More
American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states.
Read More
In small-scale tests, the nanoscale sensors distinguished a key change in the chemistry of the breath of people with lung cancer.Â
Read More
New research examines survival benefits for cancer patients who quit smoking within the first six months after diagnosis, compared to those who quit later.
Read More
During Lung Cancer Awareness Month, the American Lung Association’s Lung Force initiative is raising awareness about the role of early detection, screening, and biomarker testing in improving lung cancer survival rates.
Read More
The AI module is intended to support physicians by evaluating bronchoscopic lung forceps biopsies on-site.
Read More
The new software will leverage natural language processing capabilities to evaluate EHR data along with imaging AI to identify and triage patients suspected of lung disease.
Read More
The association has invested $22 million in research over the past year, funding 139 grants aimed at improving lung health and advancing treatments for conditions such as asthma, COPD, lung cancer, and respiratory infections.
Read More
The guideline provides nine evidence-based recommendations to standardize the collection, processing, and handling of specimens for improved lung cancer diagnosis and staging.
Read More
The FDA has approved osimertinib for adult patients with stage III NSCLC whose tumors have specific EGFR mutations, following chemoradiation therapy.
Read More
Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.
Read More
The combination regimen was approved for the first-line treatment of adults with locally advanced or metastatic non-small cell lung cancer with specific EGFR mutations.
Read More
The approval was based on trial results which showed the regimen reduced the risk of recurrence, progression, or death by 32% versus neoadjuvant chemotherapy alone.
Read More
The FDA granted Fast Track designation to Deltacel, a Gamma Delta T-cell therapy being developed for the treatment of advanced non-small cell lung cancer.
Read More
Researchers discovered that 42% of non-smoking adults had lung nodules, with 11.1% of these cases involving clinically significant nodules typically associated with higher-risk groups.
Read More
The effects of the gut microbiome on our health are far-reaching—research shows that even our lungs are influenced by this community of microbes.
Read More
Researchers say this is the first evidence that combining these habits significantly raises cancer risk.
Read More
The American Lung Association and Protect Environmental are providing access to free radon test kits to homeowners in select communities to raise awareness about radon, the second leading cause of lung cancer.
Read More
